J Natl Compr Canc Netw. 2012 Jul 1;10(7):858-914. doi: 10.6004/jnccn.2012.0089.
The inaugural NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for acute lymphoblastic leukemia (ALL) were developed as a result of meetings convened by a multi-disciplinary panel of experts in 2011. These NCCN Guidelines provide recommendations on the diagnostic evaluation and workup for ALL, risk assessment, risk-stratified treatment approaches based on the Philadelphia chromosome status and age (adults vs. adolescents/young adults), assessment of minimal residual disease, and supportive care considerations. It is recommended that patients be treated at specialized centers with expertise in the management of ALL.
《美国国家综合癌症网络临床实践指南-肿瘤学》（NCCN 指南）中的急性淋巴细胞白血病（ALL）首版是由多学科专家组于 2011 年召开会议制定的。这些 NCCN 指南提供了 ALL 的诊断评估和检查、风险评估、基于费城染色体状态和年龄（成人与青少年/青年成人）的风险分层治疗方法、微小残留病灶评估以及支持性护理注意事项的建议。建议患者在擅长 ALL 管理的专业中心接受治疗。
